Enhancer of Zeste Homolog 2 (EZH2) in Malignant Progression of Gallbladder Carcinoma

被引：0
|
作者：
Gayatri Behera
Suvradeep Mitra
Tushar S Mishra
Suvendu Purkait
机构：
[1] AIIMS,Department of Pathology and Lab Medicine
[2] AIIMS,Department of Trauma and Emergency
来源：
Journal of Gastrointestinal Cancer | 2021年 / 52卷
关键词：
Gallbladder; Carcinoma ; Dysplasia ; Epigenetic ; EZH2 ; H3K27me3; DNMT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1029 / 1034
页数：5
相关论文
共 50 条
  • [1] Enhancer of Zeste Homolog 2 (EZH2) in Malignant Progression of Gallbladder Carcinoma
    Behera, Gayatri
    Mitra, Suvradeep
    Mishra, Tushar S.
    Purkait, Suvendu
    JOURNAL OF GASTROINTESTINAL CANCER, 2021, 52 (03) : 1029 - 1034
  • [2] Enhancer of zeste homolog 2 (EZH2) inhibitors
    Gulati, Nitya
    Beguelin, Wendy
    Giulino-Roth, Lisa
    LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1574 - 1585
  • [3] Expression of Enhancer of Zeste Homolog 2 (EZH2) in Invasive Neuroendocrine Carcinoma of the Breast
    Gong, Y.
    Chen, J.
    Wang, J.
    Radvanyi, L.
    Rosen, D. G.
    Wu, Y.
    MODERN PATHOLOGY, 2013, 26 : 44A - 45A
  • [4] Expression of Enhancer of Zeste Homolog 2 (EZH2) in Invasive Neuroendocrine Carcinoma of the Breast
    Gong, Y.
    Chen, J.
    Wang, J.
    Radvanyi, L.
    Rosen, D. G.
    Wu, Y.
    LABORATORY INVESTIGATION, 2013, 93 : 44A - 45A
  • [5] Expression of enhancer of zeste homolog 2 (EZH2) in Invasive neuroendocrine carcinoma of the breast
    Gong, Y.
    Chen, J.
    Radvanyi, L.
    Rosen, D. G.
    Wu, Y.
    HISTOPATHOLOGY, 2012, 61 : 20 - 20
  • [6] Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer
    Warrick, Joshua I.
    Raman, Jay D.
    Kaag, Matthew
    Bruggeman, Trey
    Cates, Justin
    Clark, Peter
    DeGraff, David J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (06) : 258.e1 - 258.e6
  • [7] Epigenetic Control of Osteoblast Differentiation by Enhancer of Zeste Homolog 2 (EZH2)
    Amel Dudakovic
    Andre J. van Wijnen
    Current Molecular Biology Reports, 2017, 3 (2) : 94 - 106
  • [8] Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (EZH2)
    Xu, Xin
    Chen, Jia
    Wang, Guan
    Zhang, Xiaojuan
    Li, Qiang
    Zhou, Xiaobo
    Guo, Fengying
    Li, Min
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 97
  • [9] Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
    Nina Wagener
    Stephan Macher-Goeppinger
    Maria Pritsch
    Johannes Hüsing
    Karin Hoppe-Seyler
    Peter Schirmacher
    Jesco Pfitzenmaier
    Axel Haferkamp
    Felix Hoppe-Seyler
    Markus Hohenfellner
    BMC Cancer, 10
  • [10] Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
    Wagener, Nina
    Macher-Goeppinger, Stephan
    Pritsch, Maria
    Huesing, Johannes
    Hoppe-Seyler, Karin
    Schirmacher, Peter
    Pfitzenmaier, Jesco
    Haferkamp, Axel
    Hoppe-Seyler, Felix
    Hohenfellner, Markus
    BMC CANCER, 2010, 10
12345